In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Related Topics
The Overview: May 2026
When Ovarian Cancer Research Alliance (OCRA) announced the launch of the Community Accelerated Research Exchange on World Ovarian Cancer Day, the response was immediate. More than 280 media mentions. Over 171 million people reached. Television and radio coverage in English and Spanish, in markets from San Francisco to Albany. The excitement is building—and it’s just … Continued
Family Matters: OCRA’s Summer Support and Education Series
This summer, Ovarian Cancer Research Alliance (OCRA) is offering a full slate of both support and education programming. Our special Summer Series, “Family Matters,” presents Roundtables and Staying Connected sessions for patients, survivors, and loved ones. We also invite you to join us for an educational webinar on the latest treatment advances. Registration links are below. All … Continued
OCRA’s Research Exchange Announcement Reaches Over 171 Million
AI-Powered Platform Launch Sparks Nationwide Conversation The response to OCRA’s launch of the Community Accelerated Research Exchange was immediate and far-reaching. News outlets across the country picked up the story, generating more than 280 media mentions and reaching over 171 million people—a sign of just how much this groundbreaking platform, designed to connect patients, researchers, … Continued
